Correlation Between ATyr Pharma and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Coya Therapeutics, Common, you can compare the effects of market volatilities on ATyr Pharma and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Coya Therapeutics,.
Diversification Opportunities for ATyr Pharma and Coya Therapeutics,
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between ATyr and Coya is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between ATyr Pharma and Coya Therapeutics,
Given the investment horizon of 90 days ATyr Pharma is expected to under-perform the Coya Therapeutics,. In addition to that, ATyr Pharma is 1.37 times more volatile than Coya Therapeutics, Common. It trades about -0.04 of its total potential returns per unit of risk. Coya Therapeutics, Common is currently generating about 0.03 per unit of volatility. If you would invest 457.00 in Coya Therapeutics, Common on September 14, 2024 and sell it today you would earn a total of 117.00 from holding Coya Therapeutics, Common or generate 25.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 74.24% |
| Values | Daily Returns |
ATyr Pharma vs. Coya Therapeutics, Common
Performance |
| Timeline |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Coya Therapeutics, Common |
ATyr Pharma and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATyr Pharma and Coya Therapeutics,
The main advantage of trading using opposite ATyr Pharma and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |